Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Shanghai Jiaotong University School Of Medicine currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This 1 pending office action is assigned to 1 distinct examiner, which indicates a concentrated prosecution effort for the current portfolio. The data shows that the examination is occurring within 1 distinct art unit, suggesting the technical subject matter is focused within a specific area of biotechnology.
The busiest examiner for this portfolio is MITCHELL, EDWIN COLEMAN, who is currently handling 1 busiest examiner pending office action. This 1 busiest examiner pending office action constitutes the entirety of the company's current pending workload at the patent office. Consequently, the progress of the university's filings in the Biotechnology & Pharmaceuticals sector is currently tied to the review of the identified examiner.
For a practitioner, the presence of 1 distinct art unit and 1 distinct examiner means there is no variability in the current examination environment. The strategy for Shanghai Jiaotong University School Of Medicine depends on the specific requirements of MITCHELL, EDWIN COLEMAN. Navigating the pending matter requires a focused approach tailored to the practices of this identified examiner and art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MITCHELL, EDWIN COLEMAN | 1 | 31.9% | +65.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18271947 | NANOCOMPLEX, PREPARATION METHOD THEREFOR, AND USE THEREOF | MITCHELL, EDWIN COLEMAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18271947 | NANOCOMPLEX, PREPARATION METHOD THEREFOR, AND USE THEREOF | MITCHELL, EDWIN COLEMAN | — |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18271947 | NANOCOMPLEX, PREPARATION METHOD THEREFOR, AND USE THEREOF | MITCHELL, EDWIN COLEMAN | 1619 | §101§103 | Final Rejection | — | Pending | Jul 12, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialShanghai Jiaotong University School Of Medicine has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Edwin Coleman Mitchell has the most, with 1 of Shanghai Jiaotong University School Of Medicine's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.